Correlation Between Leap Therapeutics and ProPhase Labs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Leap Therapeutics and ProPhase Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Leap Therapeutics and ProPhase Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Leap Therapeutics and ProPhase Labs, you can compare the effects of market volatilities on Leap Therapeutics and ProPhase Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Leap Therapeutics with a short position of ProPhase Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Leap Therapeutics and ProPhase Labs.

Diversification Opportunities for Leap Therapeutics and ProPhase Labs

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Leap and ProPhase is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Leap Therapeutics and ProPhase Labs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProPhase Labs and Leap Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Leap Therapeutics are associated (or correlated) with ProPhase Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProPhase Labs has no effect on the direction of Leap Therapeutics i.e., Leap Therapeutics and ProPhase Labs go up and down completely randomly.

Pair Corralation between Leap Therapeutics and ProPhase Labs

Given the investment horizon of 90 days Leap Therapeutics is expected to under-perform the ProPhase Labs. In addition to that, Leap Therapeutics is 1.92 times more volatile than ProPhase Labs. It trades about -0.31 of its total potential returns per unit of risk. ProPhase Labs is currently generating about -0.28 per unit of volatility. If you would invest  76.00  in ProPhase Labs on November 1, 2024 and sell it today you would lose (33.72) from holding ProPhase Labs or give up 44.37% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Leap Therapeutics  vs.  ProPhase Labs

 Performance 
       Timeline  
Leap Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Leap Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
ProPhase Labs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ProPhase Labs has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Leap Therapeutics and ProPhase Labs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Leap Therapeutics and ProPhase Labs

The main advantage of trading using opposite Leap Therapeutics and ProPhase Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Leap Therapeutics position performs unexpectedly, ProPhase Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProPhase Labs will offset losses from the drop in ProPhase Labs' long position.
The idea behind Leap Therapeutics and ProPhase Labs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Commodity Directory
Find actively traded commodities issued by global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges